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The ﬁrst patient was an 83-year-old man who presented 
a urinary tract infection caused by E. coli following the uro-
logical surgery in December 2015. The E. coli isolate (CDF-
6) showed resistance to broad-spectrum cephalosporins, and
the patient was therefore treated by ertapenem for ten days. 
The second patient was a 75-year-old man who was admitted 
for the treatment of an adenocarcinoma in January 2016, and 
had a nephrostomy due to a renal failure. He presented a ﬁrst 
urinary tract infection caused by a Proteus mirabilis isolate.
After treatment by cefuroxime for 14 days, an E. coli isolate
showing resistance to broad-spectrum cephalosporins (CDF-
8) was recovered from urine. None of those patients received
prior treatment with polymyxin, nor traveled abroad.
Both isolates were tested for colistin resistance with the 
Rapid Polymyxin  NP® test (ELITech, Signes, France) and 
were found positive after 2 h of incubation. Disk diﬀusion 
susceptibility testing performed on Muller–Hinton (MH) 
agar (Bio-Rad, Cressier, Switzerland) showed that both iso-
lates exhibited an ESBL proﬁle. Minimal inhibitory concen-
trations (MICs) were determined using the broth microdilu-
tion method using cation-adjusted MH broth (Bio-Rad) and 
both isolates showed an MIC of colistin at 8 μg/ml. PCR 
ampliﬁcations followed by sequencing detected the mcr-1
gene in both isolates. In addition, the isolates were positive 
for the blaCTX-M-1 and blaCTX-M-15 ESBL encoding genes,
respectively. Multilocus sequence types were determined by 
ampliﬁcation and sequencing of seven housekeeping genes, 
and sequence types were assigned using the Warwick E. 
coli MLST database (http://mlst.warwick.ac.uk/mlst/dbs/
Ecoli). Phylogenetic groups were determined by the PCR-
based Clermont method consisting in the detection of spe-
ciﬁc virulence genes. Isolates CDF-6 and CDF-8 belonged 
to ST446 and ST164, respectively, and to the commensal B1 
and C phylogenetic groups, respectively. Conjugation fol-
lowed by PCR-based replicon typing analyzes and plasmid 
Sir,
The recent identiﬁcation of the transferable colistin resist-
ance genes mcr-1 and mcr-2 represents an additional step
towards the occurrence of pandrug-resistant enterobacte-
rial strains [1]. MCR-1 and MCR-2-producing Enterobac-
teriaceae are mainly recovered from animals, and particu-
larly from pigs. Conversely, rare occurrence of MCR-1 and 
MCR-2-producers has been described from clinical samples 
and the environment [2]. In Switzerland, several screening 
studies showed a low prevalence of MCR-1 and MCR-2 
producers in clinical isolates recovered from blood culture 
and urines [3, 4]. Here we report two cases of urinary tract 
infections associated with Escherichia coli isolates co-
producing an extended-spectrum β-lactamase (ESBL) and 
the polymyxin resistance determinant MCR-1, recovered 
from patients hospitalized at the hospital of Neuchâtel, 
Switzerland.
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extractions showed that the mcr-1 gene was located on a ca. 
250-kb IncHI2 and ca. 33-kb IncX4 plasmids for the CDF-6 
and CDF-8 isolates, respectively. Resistance to sulfamethox-
azole/trimethoprim and tetracycline was co-transferred with 
the IncHI2-carrying mcr-1 plasmid, whereas no co-resist-
ance was found to be associated with the IncX4-carrying 
mcr-1 plasmid. Additionally, two full copies of the insertion 
sequence ISApl1 bracketing the mcr-1 gene were identiﬁed 
on the IncHI2 plasmid, forming transposon Tn6330 [5].
That study reports on two likely community-acquired 
E. coli isolates co-producing MCR-1 and a CTX-M-like 
β-lactamase. These isolates belonged to diﬀerent sequence 
types and were not related to extra-intestinal pathogenic 
strains. Noteworthy, previous studies reported ST446 and 
ST164 E. coli from animal samples including poultry, swine 
and cattle, strengthening the likelihood of an animal origin 
for those strains. Rapid detection of colistin resistance has 
beneﬁciated from the use of the Rapid Polymyxin NP test 
that takes 2 h of incubation, whereas MIC determinations 
usually take 18 h. Noteworthy, both patients did not receive 
previous polymyxin-based treatments, suggesting a hidden 
circulation of those strains.
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